We performed amplicon sequencing to measure the percentage of CD19 alleles with an insertion/deletion mutation induced by the Cas9-gRNA and observed 64% and 65% of mean allele editing in CLL (n = 3) and MCL (n = 3), respectively. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.